Astellas, Daiichi Sankyo, and Takeda Announce Research Collaboration on Establishing Biomarker Database on Healthy Adults
Three Pharmaceutical Companies with Research Bases in Japan Work Together to Accelerate Innovation in Japan-Originated Drug DiscoveryAstellas Pharma Inc , Daiichi Sankyo Company, Limited...
AbbVies Showcased at Digestive Disease Week with New HUMIRA ,Real-World Research and Promising Anti-IL-23 Antibody Late-Breaking Data
Data presentations further evaluate HUMIRA® (adalimumab) for the treatment of inflammatory bowel diseases including moderate to severe Crohn's disease in adult and pediatric...
Osaka University concludes a comprehensive collaboration agreement with Chugai Pharmaceutical Co Ltd.
Osaka University and Chugai Pharmaceutical announced the conclusion of a comprehensive collaboration agreement for advanced research in immunology between the Osaka University...
Otsuka Holdings Announces Collaboration with ReCor Medical for Commercialization of ReCor Medical’s Ultrasound Renal Denervation Technology in Asia
Otsuka Holdings Co Ltd announced the signing of a development and commercialization agreement with ReCor Medical Inc. (“ReCor”), together with an additional investment. As...
Chugai Pharmaceutical Co Ltd announced Efficacy of Actemra Subcutaneous Injection Confirmed in Dose Interval Reduction Study in Patients with Rheumatoid Arthritis
Chugai Pharmaceutical announced that "Actemra® Subcutaneous Injection" , the humanized antihuman IL-6 receptor monoclonal antibody, successfully met the primary endpoint in a dose interval...
Pfizer Announces Results From Two Phase 3 TRUMENBA Studies At The European Society For Paediatric Infectious Diseases Meeting
Pfizer Inc announced results of two Phase 3 studies demonstrating the immunogenicity of TRUMENBA® (Meningococcal Group B Vaccine) against invasive meningococcal B (MnB)...
Biogen and Abbvie Receive Positive Opinion From The CHMP on ZINBRYTA™ (daclizumab) For Treatment Of Multiple Sclerosis
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...